This is the authors' abstract. We don't add key points for this paper.
A 71-year-old man was referred to us for investigation of a liver mass and adenomyomatosis of gallbladder. Findings on ethoxybenzyl diethylenetriamine-enhanced MRI (EOB-MRI) led to a presumptive diagnosis of a 1.5 cm hepatocellular carcinoma (HCC) in the right posterior lobe of the liver. Transcatheter arterial chemoembolization and radiofrequency ablation of the tumor were attempted. After 2 months, CT scan and EOB-MRI showed that the tumor had enlarged to 3 cm. Positron emission tomography (PET) confirmed abnormal metabolic activity with a high standardized uptake value of 7.3 in the lesion. These findings could indicate malignancy such as well-differentiated HCC or cholangiocarcinoma or a benign lesion such as hepatic abscess. Histopathological examination of a liver biopsy revealed a granuloma with many inflammatory cells, leading to a diagnosis of inflammatory pseudotumor of the liver. We report a rare case of hepatic inflammatory pseudotumor with enhancement on EOB-MRI and increased uptake on PET, mimicking HCC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Iguchi et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: